Picture of Biotech Growth Trust logo

BIOG Biotech Growth Trust Share Price

0.000.00%
gb flag iconLast trade - 00:00
FinancialsBalancedSmall Cap

Momentum

Relative Strength (%)
1m+0.57%
3m+4.9%
6m+22.33%
1yr+28.31%
Volume Change (%)
10d/3m+20.82%
Price vs... (%)
52w High-4.16%
50d MA+2.47%
200d MA+17.77%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-31.33%
Return on Equity-25.77%
Operating Margin105.66%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Biotech Growth Trust EPS forecast chart

Profile Summary

The Biotech Growth Trust PLC is a United Kingdom-based investment trust. The Company's investment objective is to seek capital appreciation through investment in the biotechnology industry across the world. It invests in a diversified portfolio of shares and related securities in biotechnology companies. The Company invests approximately 10% in aggregate of the value of its gross assets in other closed-ended investment companies, including investment trusts listed on the London Stock Exchange. The Company invests approximately 15% of the value of its gross assets in any one individual stock at the time of acquisition. Its portfolio of investments across various countries includes Netherlands, the United States of America, Canada, and China. The Company’s alternative investment fund manager is Frostrow Capital LLP.

Directors

Last Annual
March 31st, 2023
Last Interim
September 30th, 2023
Incorporated
May 20th, 1997
Public Since
June 23rd, 1997
Sector
Collective Investments
Industry
Financials
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
33,487,198

BIOG Share Price Performance

Upcoming Events for BIOG

Full Year 2024 Biotech Growth Trust PLC Earnings Release

Biotech Growth Trust PLC Annual Shareholders Meeting

Similar to BIOG

Picture of 3i Infrastructure logo

3i Infrastructure

gb flag iconLondon Stock Exchange

Picture of Abrdn Asia Focus logo

Abrdn Asia Focus

gb flag iconLondon Stock Exchange

Picture of abrdn Asian Income Fund logo

abrdn Asian Income Fund

gb flag iconLondon Stock Exchange

FAQ